Mechanism of ligustrazini against thrombosis

Chinese Medical Journal

Volumn 113, Issue 2, 2000, Pages 136-139

  Song, Jianxin ^a   Ruan, Qiurong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ligustrazini; Mechanism; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CHINESE DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGUSTRAZINI; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; HUMAN CELL; NORTHERN BLOTTING; SEPTIC SHOCK; THROMBOSIS; UMBILICAL VEIN;

BINDING, COMPETITIVE; BLOTTING, NORTHERN; CELLS, CULTURED; DRUGS, CHINESE HERBAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HUMANS; NF-KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRAZINES; RNA, MESSENGER; THROMBOSIS;

EID: 0038062849     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Loskutoff DJ. Regulation of PAI-1 gene expression. Fibrinolysis 1991;5:197-201.
2. Emeis JJ, Kooistra T. Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986;163:1260-1266.
3. Pralong G, Calandra T, Glauser MP, et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989;61:459-462.
4. Lupu F, Bergonzelli GE, Heim DA, et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993;13:1090-1100.
5. Ruan QR, Deng ZD, Xu ZS, et al. Monocyte chemotactic factor produced by human unbilical endothelial cells in vitro. Chin J Pathol 1991;20:205-208.
6. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 1989;86:2336-2340.
7. Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A 1992;89:6998-7002.
8. Hamsten A, de Faire U, Walldius C, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3-6.
9. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 1993;68:499-508.